Keros Therapeutics, Inc. · NASDAQ:KROS
Nantahala Capital Management, LLC reported a 6.90% stake in Keros Therapeutics, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed May 15, 2026
Nantahala Capital Management, LLC reported a 6.90% stake in Keros Therapeutics, Inc., 1,360,419 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G).
- Stake
- 6.90%
- Shares
- 1,360,419
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Nantahala Capital Management, LLC | 6.90% | 1,360,419 |
| Wilmot B. Harkey | 6.90% | 1,360,419 |
| Daniel Mack | 6.90% | 1,360,419 |